Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
Zhu H, Xue X, Wang E, Wallack M, Na H, Hooker JM, Kowall N, Tao Q, Stein TD, Wolozin B, Qiu WQ.
Zhu H, et al. Among authors: wallack m.
Neuropharmacology. 2017 Jun;119:170-181. doi: 10.1016/j.neuropharm.2017.03.030. Epub 2017 Mar 28.
Neuropharmacology. 2017.
PMID: 28363773
Free PMC article.